Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 9,109 $ 8,408
Restricted cash 0 250
Marketable debt securities, available for sale 8,328 8,779
Marketable equity securities, at fair value 0 76
Accounts receivable, net 37,054 37,708
Inventory, net 3,976 4,600
Prepaid expenses and other current assets 2,366 1,496
Total current assets 60,833 61,317
Property, plant and equipment, net 7,288 5,947
Prepaid expenses, net of current portion 121 460
Right-of-use asset, net 4,059 4,402
Intangible assets, net 8,475 10,852
Goodwill 5,709 5,709
Other assets 1,163 608
TOTAL ASSETS 87,648 89,295
Current liabilities    
Accounts payable 5,905 7,026
Accrued diagnostic services 1,009 1,890
Accrued advertising and other allowances 99 104
Lease liabilities 301 663
Deferred revenue 2,499 2,034
Income tax payable 4,190 1,312
Other current liabilities 2,072 2,495
Total current liabilities 16,075 15,524
Non-current liabilities:    
Deferred revenue, net of current portion 1,059 905
Deferred tax liability, net 224 0
Note payable 0 44
Unsecured convertible promissory notes, net 2,400 9,996
Lease liabilities, net of current portion 4,259 4,198
Total non-current liabilities 7,942 15,143
Total liabilities 24,017 30,667
COMMITMENTS AND CONTINGENCIES
Stockholders’ equity    
Preferred stock authorized 1,000,000, $0.0005 par value, no shares issued and outstanding 0 0
Common stock authorized 50,000,000, $0.0005 par value, 16,210,776 and 15,485,900 shares outstanding, respectively 16 16
Additional paid-in capital 109,138 104,552
Retained earnings (accumulated deficit) 11,753 2,642
Treasury stock, at cost, 18,126,970 and 16,818,846 shares, respectively (58,033) (48,407)
Accumulated other comprehensive loss 757 (175)
Total stockholders’ equity 63,631 58,628
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 87,648 $ 89,295